Anbio Biotechnology (NNNN) Current Assets (2023 - 2025)

Anbio Biotechnology's Current Assets history runs 3 years deep, the most recent figure standing at $30.2 million for Q4 2025.

• In Q4 2025, Current Assets rose 63.17% year-over-year to $30.2 million; the TTM figure through Dec 2025 stood at $30.2 million (up 63.17% YoY), while the FY2025 annual figure was $30.2 million, up 63.17% from the prior year.
• Current Assets was $30.2 million for Q4 2025 at Anbio Biotechnology, down from $27680.6 billion in the prior quarter.
• In the past five years, Current Assets ranged from a high of $27680.6 billion in Q2 2025 to a low of $15.7 million in Q4 2023.
• Historically, Current Assets has averaged $6920.2 billion across 3 years, with a median of $24.4 million in 2024.
• The sharpest annual moves came in 2024 and 2025: Current Assets gained 17.68% in 2024, then surged 63.17% in 2025.
• A 3-year view of Current Assets shows it stood at $15.7 million in 2023, then rose by 17.68% to $18.5 million in 2024, then soared by 63.17% to $30.2 million in 2025.
• The last three Current Assets figures came in at $30.2 million (Q4 2025), $27680.6 billion (Q2 2025), and $18.5 million (Q4 2024), per Business Quant data.